Back
Cadrenal Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
CVKD
Cadrenal Therapeutics
Last Price:
$12.00
Seasonality Move:
6.63%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVKD is experiencing slight selling pressure.
Cadrenal Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.81 | Sell |
| 20-day SMA: | 12.32 | Buy |
| 50-day SMA: | 13.89 | Sell |
| 200-day SMA: | 15.66 | Sell |
| 8-day EMA: | 12.63 | Sell |
| 20-day EMA: | 12.73 | Sell |
| 50-day EMA: | 13.76 | Sell |
| 200-day EMA: | 14.57 | Sell |
Cadrenal Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 45.79 | Sell |
| Chaikin Money Flow: | -9328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.42 - 14.3) | Sell |
| Bollinger Bands (100): | (13.28 - 18.18) | Sell |
Cadrenal Therapeutics Technical Analysis
| Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cadrenal Therapeutics Stock
Is Cadrenal Therapeutics Stock a Buy?
-
Cadrenal Therapeutics share price is 12.50 while CVKD 8-day simple moving average is 12.81, which is a Sell signal.
-
The stock price of CVKD is 12.50 while Cadrenal Therapeutics 20-day SMA is 12.32, which makes it a Buy.
-
Cadrenal Therapeutics 50-day simple moving average is 13.89 while CVKD share price is 12.50, making it a Sell technically.
-
CVKD stock price is 12.50 and Cadrenal Therapeutics 200-day simple moving average is 15.66, creating a Sell signal.
CVKD Technical Analysis vs Fundamental Analysis
Sell
33
Cadrenal Therapeutics (CVKD)
is a Sell
Is Cadrenal Therapeutics a Buy or a Sell?
-
Cadrenal Therapeutics stock is rated a SellThe current Cadrenal Therapeutics [CVKD] share price is $12.50. The Score for CVKD is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Cadrenal Therapeutics Stock Info
Market Cap:
24.6M
Price in USD:
12.50
Share Volume:
20K
Cadrenal Therapeutics 52-Week Range
52-Week High:
22.90
52-Week Low:
5.70
Sell
33
Cadrenal Therapeutics (CVKD)
is a Sell
Cadrenal Therapeutics Share Price Forecast
-
What is the Cadrenal Therapeutics stock price today?The Cadrenal Therapeutics stock price is 12.50 USD today.
-
Will CVKD stock go up or go down?Cadrenal Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cadrenal Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cadrenal Therapeutics is overvalued.
Is Cadrenal Therapeutics Stock a Buy?
-
Cadrenal Therapeutics share price is 12.50 while CVKD 8-day exponential moving average is 12.63, which is a Sell signal.
-
The stock price of CVKD is 12.50 while Cadrenal Therapeutics 20-day EMA is 12.73, which makes it a Sell.
-
Cadrenal Therapeutics 50-day exponential moving average is 13.76 while CVKD share price is 12.50, making it a Sell technically.
-
CVKD stock price is 12.50 and Cadrenal Therapeutics 200-day simple moving average is 14.57, creating a Sell signal.
Fundamental Analysis of Cadrenal Therapeutics
Is Cadrenal Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $2.54 per share.
Technical Analysis of Cadrenal Therapeutics
Should I short Cadrenal Therapeutics stock?
-
CVKD Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Cadrenal Therapeutics is a Sell
-
Cadrenal Therapeutics Relative Strength Index (RSI) is 45.79, which suggest Cadrenal Therapeutics is oversold
-
The Bollinger Bands (25) for Cadrenal Therapeutics is (11.42 - 14.3), which suggest Cadrenal Therapeutics is a Sell
-
The Bollinger Bands (100) for Cadrenal Therapeutics is (13.28 - 18.18), which suggest Cadrenal Therapeutics is a Sell
* Cadrenal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.